Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.9
4.9
Journals
Pharmaceutics
Special Issues
Research on the Prediction and Optimization of the Solubility and...
share announcement

Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 4838

Special Issue Editors

Prof. Dr. Marta González-Álvarez

E-Mail Website
Guest Editor
Department of Engineering and Pharmaceutical Technology, Faculty of Pharmacy, Miguel Hernandez University, 03550 Alicante, Spain
Interests: dissolutión; controlrelease; disintegration; drug development
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Isabel Gonzalez-Alvarez

E-Mail Website
Guest Editor
Pharmacokinetics and Pharmaceutical Technology Area, Miguel Hernandez University, San Juan de Alicante, 03550 Alicante, Spain
Interests: PBPK; biowaivers; pharmacokinetics; dissolution; absorption; drug solubility
Special Issues, Collections and Topics in MDPI journals
Dr. Alejandro Ruiz-Picazo

E-Mail Website
Guest Editor
Department of Engineering and Pharmaceutical Technology, Faculty of Pharmacy, Miguel Hernandez University, 03550 Alicante, Spain
Interests: dissolution; pharmacokinetics; permeability; bioavailability

Special Issue Information

Dear Colleagues,

The Biopharmaceutical Classification System (BCS) is widely used by both regulatory agencies and the pharmaceutical industry. This classification considers the solubility and permeability of drugs. The development of in vitro biopredictive methods for estimating the solubility and permeability of pharmaceutical formulations is a topic of general interest, particularly in recent years. The formulation of pharmacological molecules in conjunction with solubility enhancers and intestinal permeability enhancers is common practice today. These methods are especially useful for the optimization of these formulations before advancing to later stages of the drug development process. This can help provide patients with safer, effective, and high-quality medication in less time and at a lower cost.

In this Special Issue, we aim to highlight recent advances in drug formulation development and biopredictive tools to analyze liberation and absorption processes. We welcome original research and review articles highlighting the latest advances in dissolution and permeability tests.

We look forward to receiving your contributions.

Prof. Dr. Marta González-Álvarez
Prof. Dr. Isabel Gonzalez-Alvarez
Dr. Alejandro Ruiz-Picazo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biopredictive test
  • drug delivery systems
  • in vitro/in vivo studies
  • drug development
  • generic industry
  • dissolution test
  • absorption
  • permeability
  • biowaivers

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

15 pages, 2181 KiB  
Article
In Vivo Relevance of a Biphasic In Vitro Dissolution Test for the Immediate Release Tablet Formulations of Lamotrigine
by Tuba Incecayir and Muhammed Enes Demir
Pharmaceutics 2023, 15(10), 2474; https://doi.org/10.3390/pharmaceutics15102474 - 17 Oct 2023
Viewed by 2087
Abstract
Biphasic in vitro dissolution testing is an attractive approach to reflect on the interplay between drug dissolution and absorption for predicting the bioperformance of drug products. The purpose of this study was to investigate the in vivo relevance of a biphasic dissolution test [...] Read more.
Biphasic in vitro dissolution testing is an attractive approach to reflect on the interplay between drug dissolution and absorption for predicting the bioperformance of drug products. The purpose of this study was to investigate the in vivo relevance of a biphasic dissolution test for the immediate release (IR) formulations of a Biopharmaceutics Classification System (BCS) Class II drug, lamotrigine (LTG). The biphasic dissolution test was performed using USP apparatus II with the dual paddle modification. A level A in vitro-in vivo correlation (IVIVC) was constructed between the in vitro partition into the octanol and absorption data of the reference product. A good relation between in vitro data and absorption was obtained (r2 = 0.881). The one-compartment open model was introduced to predict the human plasma profiles of the test product. The generic product was found to be bioequivalent to the original product in terms of 80–125% bioequivalence (BE) criteria (85.9–107% for the area under the plasma concentration curve (AUC) and 82.7–97.6% for the peak plasma concentration (Cmax) with a 90% confidence interval (CI)). Overall, it was revealed that the biphasic dissolution test offers a promising ability to estimate the in vivo performance of IR formulations of LTG, providing considerable time and cost savings in the development of generic drug products. Full article
(This article belongs to the Special Issue Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals)
►▼ Show Figures

Graphical abstract

18 pages, 6069 KiB  
Article
Topical Micro-Emulsion of 5-Fluorouracil by a Twin Screw Processor-Based Novel Continuous Manufacturing Process for the Treatment of Skin Cancer: Preparation and In Vitro and In Vivo Evaluations
by Ajinkya Nitin Nikam, Angela Jacob, Ruchira Raychaudhuri, Gasper Fernandes, Abhijeet Pandey, Vinay Rao, Sheikh F. Ahmad, Ananth S. Pannala and Srinivas Mutalik
Pharmaceutics 2023, 15(9), 2175; https://doi.org/10.3390/pharmaceutics15092175 - 22 Aug 2023
Cited by 3 | Viewed by 1815
Abstract
5-Fluorouracil (5-FU), a BCS class III drug, has low oral bioavailability and is cytotoxic in nature causing severe systemic side effects when administered through the intravenous route. Topical drug delivery could potentially mitigate the systemic side-effects. Microemulsions (MEs) would be an apt solution [...] Read more.
5-Fluorouracil (5-FU), a BCS class III drug, has low oral bioavailability and is cytotoxic in nature causing severe systemic side effects when administered through the intravenous route. Topical drug delivery could potentially mitigate the systemic side-effects. Microemulsions (MEs) would be an apt solution due to enhanced partitioning of the drug to the skin. However, conventional methods for preparing MEs are inefficient since they are not continuous and are very tedious and time-consuming processes hence revealing the need for the development of continuous manufacturing technology. In our study, 5-FU MEs were prepared using a continuous manufacturing Twin Screw Process (TSP) and its efficiency in the treatment of skin cancer was evaluated. Water-in-oil MEs were prepared using isopropyl myristate as the oil phase and Aerosol OT and Tween 80 as the surfactants. The average particle size was observed to be 178 nm. Transmission electron microscopy was employed to confirm the size and shape of the MEs. FTIR study proved no physical or chemical interaction between the excipients and the drug. In vitro drug release using vertical diffusion cells and ex vivo skin permeation studies showed that the drug was released sustainably and permeated across the skin, respectively. In in vitro cytotoxicity studies, 5-FU MEs were accessed in HaCat and A431 cell lines to determine percentage cell viability and IC50. Skin irritation and histopathological examination implied that the 5-FU MEs did not cause any significant irritation to the skin. In vivo pharmacodynamics studies in rats suggested that the optimised formulation was effective in treating squamous cell carcinoma (SCC). Therefore, 5-FU MEs efficiently overcame the various drawbacks faced during oral and intravenous drug delivery. Also, TSP proved to be a technique that overcomes the various problems associated with the conventional methods of preparing MEs. Full article
(This article belongs to the Special Issue Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop